rss
Heart 98:892 doi:10.1136/heartjnl-2012-301957
  • PostScript
  • Correspondence

The Author's reply

  1. Edward P Gerstenfeld
  1. Correspondence to Dr Edward P Gerstenfeld, Associate Professor of Medicine, University of California, San Francisco, MUE-4th Floor, 500 Parnassus Ave, San Francisco, CA 94143, USA; egerstenfeld{at}medicine.ucsf.edu

The Author's reply Dr Ward feels that I have given ‘short shrift’ to the cryoballoon in my commentary on the National Institute of Health and Clinical Excellence (NICE) guidelines for laser balloon ablation.1 2 I certainly welcome Dr Wards' comments and summary of cryoballoon efficacy, but feel a few additional comments are necessary.

First, Dr Ward points out that my comments may be biased because I have a ‘vested interest’ in the laser balloon. It should be noted that while I have received an investigator initiated research grant to perform preclinical work with the laser balloon (as declared in the editorial), I have no other consulting role with the company nor have I received any payment for work with the company. As a physician who spends a large part of my time performing atrial fibrillation …

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Heart.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article